awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33346607-1E59A26E-0E6E-4EDE-B6C4-F78F6A524885
Q33346607-1E59A26E-0E6E-4EDE-B6C4-F78F6A524885
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33346607-1E59A26E-0E6E-4EDE-B6C4-F78F6A524885
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
P2860
Q33346607-1E59A26E-0E6E-4EDE-B6C4-F78F6A524885
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33346607-1E59A26E-0E6E-4EDE-B6C4-F78F6A524885
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
105385a111a425f326409a99fe92f6d54efeb79b
P2860
Rituximab dose-escalation trial in chronic lymphocytic leukemia.